HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Yuanyuan Zhao Selected Research
Yuanyuan Zhao Research Topics
Disease
75
Neoplasms (Cancer)
04/2022 - 06/2008
19
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 06/2008
12
Stomach Neoplasms (Stomach Cancer)
04/2022 - 01/2014
12
Nasopharyngeal Carcinoma
03/2022 - 12/2014
12
Neoplasm Metastasis (Metastasis)
01/2022 - 03/2015
10
Breast Neoplasms (Breast Cancer)
01/2022 - 08/2014
9
Inflammation (Inflammations)
03/2022 - 01/2014
9
Hepatocellular Carcinoma (Hepatoma)
12/2021 - 01/2013
9
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2021 - 03/2010
7
Insulin Resistance
07/2022 - 01/2016
7
Infections
01/2022 - 09/2014
6
Reperfusion Injury
12/2022 - 01/2017
6
COVID-19
10/2022 - 07/2020
6
Carcinogenesis
12/2021 - 08/2014
5
Body Weight (Weight, Body)
07/2022 - 08/2016
5
Lung Neoplasms (Lung Cancer)
06/2022 - 10/2015
5
Coronary Artery Disease (Coronary Atherosclerosis)
02/2018 - 09/2010
4
Pathologic Constriction (Stenosis)
08/2022 - 01/2020
4
Non-alcoholic Fatty Liver Disease
03/2022 - 07/2017
4
Myocardial Infarction
01/2022 - 11/2013
4
Disease Progression
12/2021 - 06/2008
4
Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 09/2010
4
Atrial Fibrillation
01/2021 - 07/2010
4
Obesity
01/2021 - 01/2016
4
Diarrhea
01/2019 - 01/2014
3
Myocardial Ischemia (Ischemic Heart Diseases)
12/2022 - 01/2015
3
Pathologic Complete Response
01/2022 - 10/2020
3
Cardiac Arrhythmias (Arrythmia)
01/2021 - 07/2015
3
Fatty Liver
01/2021 - 12/2016
3
Liver Cirrhosis (Hepatic Cirrhosis)
01/2021 - 05/2015
3
Abdominal Aortic Aneurysm
02/2020 - 09/2010
3
Carcinoma (Carcinomatosis)
01/2020 - 05/2014
3
Exanthema (Rash)
01/2019 - 01/2014
3
Fibrosis (Cirrhosis)
01/2019 - 05/2015
3
Vomiting
08/2018 - 01/2016
3
Nausea
08/2018 - 01/2016
3
Hypoxia (Hypoxemia)
01/2018 - 05/2014
2
Type 2 Diabetes Mellitus (MODY)
02/2022 - 12/2019
2
Cerebral Infarction
01/2022 - 10/2019
2
Gestational Diabetes (Gestational Diabetes Mellitus)
01/2022 - 11/2020
2
Triple Negative Breast Neoplasms
01/2022 - 06/2021
2
Intracranial Arteriosclerosis (Cerebral Atherosclerosis)
01/2022 - 06/2020
2
Atherosclerosis
10/2021 - 03/2016
2
Chronic Obstructive Pulmonary Disease (COPD)
03/2021 - 09/2010
2
Brain Ischemia (Cerebral Ischemia)
02/2021 - 10/2019
Drug/Important Bio-Agent (IBA)
20
Pharmaceutical Preparations
IBA
08/2022 - 06/2008
13
Biomarkers (Surrogate Marker)
IBA
06/2022 - 01/2012
13
Proteins (Proteins, Gene)
FDA Link
04/2022 - 10/2011
10
Lipids
IBA
03/2022 - 01/2013
9
Tyrosine Kinase Inhibitors
IBA
06/2020 - 01/2012
9
ErbB Receptors (EGF Receptor)
IBA
02/2020 - 01/2012
8
Glucose (Dextrose)
FDA Link
Generic
07/2022 - 01/2018
8
Messenger RNA (mRNA)
IBA
04/2022 - 01/2013
7
Cisplatin (Platino)
FDA Link
Generic
06/2022 - 01/2016
7
Biological Products
IBA
03/2022 - 01/2015
7
Gefitinib (Iressa)
FDA Link
06/2020 - 01/2012
6
Small Interfering RNA (siRNA)
IBA
06/2022 - 08/2014
6
Cytokines
IBA
01/2021 - 01/2014
5
Indicators and Reagents (Reagents)
IBA
06/2022 - 10/2011
5
Ligands
IBA
04/2022 - 07/2014
5
MicroRNAs (MicroRNA)
IBA
01/2020 - 07/2014
4
Therapeutic Uses
IBA
10/2022 - 07/2015
4
Triglycerides (Triacylglycerol)
IBA
07/2022 - 12/2020
4
C-Reactive Protein
IBA
11/2021 - 01/2015
4
Albumins
IBA
11/2021 - 01/2015
4
Afatinib
IBA
01/2021 - 01/2014
4
Sodium Channels (Sodium Channel)
IBA
08/2019 - 07/2010
4
Fluorouracil (Carac)
FDA Link
Generic
02/2019 - 01/2013
3
Solutions
IBA
12/2022 - 01/2013
3
Fatty Acids (Saturated Fatty Acids)
IBA
10/2022 - 01/2018
3
Blood Glucose (Blood Sugar)
IBA
07/2022 - 01/2017
3
Enzymes
IBA
03/2022 - 12/2019
3
Doxorubicin (Adriamycin)
FDA Link
Generic
03/2022 - 06/2018
3
RNA (Ribonucleic Acid)
IBA
01/2022 - 07/2014
3
Histones (Histone)
IBA
01/2021 - 07/2014
3
LDL Cholesterol
IBA
01/2021 - 01/2017
3
osimertinib
IBA
01/2021 - 02/2020
3
Oxaliplatin (Eloxatin)
FDA Link
Generic
12/2020 - 12/2016
3
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
01/2020 - 07/2014
3
Alanine Transaminase (SGPT)
IBA
01/2019 - 10/2018
2
5- (3- (4- (4- benzylpiperazin- 1- yl)- N- (4- phenylthiazol- 2- yl))propanamide
IBA
12/2022 - 02/2019
2
Cholesterol
IBA
07/2022 - 06/2021
2
Antigens
IBA
03/2022 - 12/2019
2
Nucleic Acids
IBA
03/2022 - 10/2021
2
Insulin (Novolin)
FDA Link
02/2022 - 09/2010
2
Hypoglycemic Agents (Hypoglycemics)
IBA
02/2022 - 08/2020
2
Sugars
IBA
02/2022 - 01/2018
2
HLA-G Antigens (HLA G)
IBA
01/2022 - 11/2020
2
Crizotinib
IBA
01/2022 - 01/2015
2
Transforming Growth Factors (Transforming Growth Factor)
IBA
01/2022 - 01/2022
2
camrelizumab
IBA
12/2021 - 10/2018
2
Plant Extracts
IBA
02/2021 - 10/2019
Therapy/Procedure
25
Therapeutics
01/2022 - 03/2010
19
Drug Therapy (Chemotherapy)
06/2022 - 06/2008
8
Radiotherapy
03/2022 - 02/2013
5
Immunotherapy
03/2022 - 01/2019
4
Liver Transplantation
10/2021 - 01/2020
3
Neoadjuvant Therapy
01/2022 - 10/2020
3
Chemoradiotherapy
12/2020 - 01/2018
2
Heart Transplantation (Grafting, Heart)
12/2022 - 01/2020